Valiant organics Limited has scheduled a Board of Directors meeting for February 13, 2026, to review and approve its quarterly financial performance. The company has formally notified both stock exchanges about this important corporate development under regulatory compliance requirements.

Board Meeting Details

The meeting agenda focuses on the consideration and approval of crucial financial documents for the third quarter of fiscal year 2026.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing both major Indian stock exchanges about the scheduled board meeting. This notification aligns with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates advance intimation of board meetings where financial results will be considered.

The board may also address additional business matters with the chairperson's permission during the meeting.

Trading Window Closure

In accordance with insider trading regulations, Valiant Organics Limited has implemented a trading window closure for its securities. The restriction period extends until February 15, 2026, following the company's earlier intimation dated December 26, 2025.

The company has communicated these developments to both BSE Limited and National Stock Exchange of India Limited, ensuring transparency and regulatory compliance in its corporate governance practices.

Valiant Organics Limited, a leading manufacturer of specialty chemicals, held its 20th Annual General Meeting (AGM) on September 26, where shareholders approved several important resolutions, including key appointments and the selection of a new secretarial auditor.

Director Re-appointments

The shareholders re-appointed two directors to the company's board:

1. Shri Mahek M. Chheda was re-appointed as an Executive Director. With over eight years of experience, Chheda brings expertise in finance, marketing, human resources, and business development to the company.

2. Shri Kiritkumar H. Desai was re-appointed as a Non-Executive Director. Desai boasts an impressive 32-year career in research and development and quality control within the chemical and pharmaceutical industries. His experience includes developing more than 200 products.

Both directors will be liable to retire by rotation, as per the company's articles.

New Secretarial Auditor

In a move to enhance corporate governance, the shareholders approved the appointment of M/s Mehta & Mehta as the company's Secretarial Auditor. The firm will serve for five consecutive years, from the financial year 2025-26 to 2029-30. M/s Mehta & Mehta brings over 25 years of experience in legal and secretarial consultancy services to Valiant Organics.

Other Key Developments

The AGM, conducted through video conferencing and other audio-visual means, also addressed several other important matters:

• The company presented its audited financial statements for the year ended March 31.
• Shareholders approved the remuneration for Shri Sathiababu K. Kallada, Managing Director of the company.
• Material related party transactions with several entities, including Aarti Industries Limited and Valiant Laboratories Limited, were approved.
• The remuneration for the Cost Auditor for the financial year 2025-26 was ratified.

Financial Highlights

During the meeting, the company's Executive Director and Chief Financial Officer, Shri Mahek M. Chheda, presented an overview of Valiant Organics' financial performance:

Company Overview

Valiant Organics Limited, incorporated in 1984, is a specialty chemicals manufacturer headquartered in Mumbai, India. The company focuses on producing chemicals for various industries, including agrochemicals, pharmaceuticals, dyes, and pigments. With six manufacturing units across five locations and a total production capacity of 70,000 TPA, Valiant Organics has established itself as a significant player in the chlorophenol derivatives and PNA manufacturing sectors.

The AGM concluded with a Q&A session where shareholders had the opportunity to engage with the management on various aspects of the company's operations and future strategies.

As Valiant Organics moves forward with its newly appointed leadership and auditor, the company aims to strengthen its position in the specialty chemicals market while maintaining its commitment to quality and growth.